CPHI Milan 2026

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Risk Management in Pharmaceutical Manufacturing

    The pharmaceutical industry operates under strict regulatory oversight because medicines directly affect patient health and safety Manufacturers must consistently produce products that meet predefined standards of quality safety efficacy identity strength and purity Achieving these objectives requires a proactive approach to identifying and controlling risks throughout the product lifecycle

    Digital Biomarkers and Wearables: Transforming Clinical Trial Data Collection

    A participant enrolled in a week pharmaceutical trial may spend fewer than six hours inside a clinical site The remaining odd hours of that year the stairs the fatigue the broken nights the good days and the collapsed ones pass unrecorded Clinical development has quietly accepted this trade for decades building enormous capital decisions on a handful of supervised snapshots taken under artificia...

    Circular Logistics: A Strategic Advantage for U.S. Pharmaceutical Supply Chains in an Era of Uncertainty

    Temperaturerelated failures are estimated to cost the industry billion annually highlighting a nonnegotiable requirement for reliability product integrity and regulatory compliance For manufacturers

    Cell and Gene Therapy's Trillion-Dollar Reckoning Is Here

    Cell and gene therapies can cure diseases once thought untreatable Yet a string of commercial collapses now suggests that curing the patient and sustaining the business are two very different challenges and the industry is confronting the gap at last

    Biosimilars in Europe: Expanding Access and Reducing Costs

    The use of biosimilars as a part of modern health care systems is also fairly important especially in the context of the European Union as they can enhance the availability of the required treatments and reduce the costs of the health care sector As biologic medicines are recognized as firstline treatments for critical illnesses such as cancer autoimmune diseases and rheumatoid arthritis biosimila...

    How Predictive Maintenance Reduces Downtime in Pharma Plants

    The pharmaceutical industry is always under stress to enhance the reliability of the production adherence to the regulations and quality of the products without raising the prices and to maintain a continuous supply Machinery malfunctions are not merely a setback in this highstakes game they may compromise batch integrity postpone life and death treatments and put pressure on the market promises

TOP ARTICLES

press releases Read more...

Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Alkermes plc Nasdaq ALKS today announced positive topline results from a phase proofofconcept study evaluating ALKS the companys novel investigational orexin receptor OXR agonist in development

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

Precigen Inc Nasdaq PGEN a commercialstage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Amneal Pharmaceuticals Inc Amneal or the Company NASDAQ AMRX today announced that the US Food and Drug Administration FDA has approved its lanreotide injection mg mL in a sterile

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer

Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

LATEST NEWS Read more...

PTC Completes Acquisition of ST-920 Gene Therapy for Fabry Disease

PTC Therapeutics has completed its previously announced agreement with Sangamo Therapeutics to acquire ST isaralgagene civaparvovec a onetime AAV gene therapy candidate being developed for Fabry disease

Made Scientific Expands U.S. GMP Cell Therapy Network with Pennsylvania Acquisition

Made Scientific has acquired an sq ft cell therapy manufacturing facility in East Norriton Pennsylvania from National Resilience The transaction was completed on September expanding

BioCytics and Eremid collaborate on single-cell sequencing study for cancer cell therapy

BioCytics Inc has engaged Eremid Genomic Services to sequence an autologous immune cell fraction being developed for its immunebased cancer cell therapy programme

MAbxience and Sandoz collaborate to advance global access to emicizumab biosimilar

MAbxience majorityowned by Fresenius SE Co KGaA with partial ownership from Insud Pharma has entered into a licensing development manufacturing and commercialisation agreement with Sandoz for an emicizumab

Orbis Medicines enters multi-target drug discovery partnership with Novo Nordisk

Orbis Medicines has entered a strategic collaboration and licence agreement with Novo Nordisk to discover and develop nextgeneration oral macrocycle medicines for cardiometabolic diseases

Everest Clinical Research expands global biometrics capabilities with Firma DS acquisition

Everest Clinical Research has acquired the Biometrics and Data Services business unit of Firma Clinical Research expanding its global biometrics expertise and clinical data science capabilities